1 / 38

EU-US Innovation Seminar

EU-US Innovation Seminar. John Fraser AUTM, Immediate Past-President Executive Director, Commercialization Florida State University. Florida State University. Global Pharmaceutical Regulation 2007: Tackling Regional Priorities Florida State University College of Law

chiara
Download Presentation

EU-US Innovation Seminar

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EU-US Innovation Seminar John Fraser AUTM, Immediate Past-President Executive Director, Commercialization Florida State University

  2. Florida State University Global Pharmaceutical Regulation 2007: Tackling Regional Priorities Florida State University College of Law Tallahassee, Florida April 5-7, 2007 Prof Fred Abbott: FAbbott@law.fsu.edu Attendees: Individuals from – WHO, WIPO, MSF; PAHO; Washington DC, Argentina, India, etc

  3. What is AUTM? • The professional association that brings together 3500 technology transfer professionals in more than 30 countries to define, develop and promote leadership excellence in academic technology transfer • 66% are employed in academic technology transfer offices. 33% are in corporations, service businesses or government. • 80% reside in the US, 9% in Canada and 11% in other countries. • 2050 attendees at AGM in San Fran from 36 countries

  4. What do we do ? We impact the economy by partnering with the private sector to develop products that save lives, improve the quality of life and increase productivity and competitiveness.

  5. The Mission Universities have a social contract with society. In return for public funding, universities will educate the next generation, create knowledge about the world and its problems and perform community service (clinical studies, economic development). Academic technology transfer is a relatively new activity within the social contract.

  6. The Mission To enhance the reputation of our institution by helping them achieve their goals of education research and community service by facilitating research partnerships with the private sector to the long term benefit of all. Build the research base ! The strategy is to assist development of products with an outcome of saving lives, improving the quality of life and enhancing productivity and global competitiveness.

  7. I will talk about: What we do. and How well we do it. Outcomes, Impact, not inputs and outputs.

  8. Purpose of Bayh-Dole Act • Created to specify with certainty, the ownership of inventions from federally funded research in universities and small businesses. • Created to provide incentives and responsibility for commercialization. • Created as a Job Creation Act and an Economic Development Act. • Insisted on manufacturing in the USA.

  9. Sequential model of development and funding

  10. Outputs: Growing volume of US academic technology transfer • $41 billion in US R&D expenditures (FY’05); • 4,932 new licenses; • 28,349 current active licenses; • 527 new products introduced in the market; • 3,641 new product introductions in last 8 years • 628 new spinout companies; • 5,171 new spinouts since 1980.

  11. New Metrics • Recognition that technology transfer is part of the core mission of the academic institution. • Its impact is beyond the traditional AUTM metrics. • Its external impact is to society – outcomes - in lives saved, patients with improved quality of life and increasing industrial productivity

  12. New, New, New • AUTM practitioners are reaching out to academic scholars to research our field; • In the Public Interest: Nine Points to Consider in Licensing University Technology(Chronicle of Higher Education – Mar 7/07); • New Metrics: (outside TTO, internal Univ; outside Univ, community based); • Embracing our role in local economic development; • Preliminary results of publicly funded research inventing a molecule now a FDA approved drug.

  13. Where is the Action ? • Fiscal Year 2004, billions • University expenditures for research: $ 42.3 • From federal sources: $ 28.3 (67%) • From Industry: $ 3.0 (7%) • University Licensing Income: $ 1.4 billion • FY 1996. % licensing deals in life sciences – 64%. % income from life sciences 80%

  14. Where is the Action ?

  15. Gardeners in the Garden with Tools over Time

  16. From Disclosure to Patent Royalties AUTM Data FY 1991-2000 $200B + Research $2M : 1 disclosure • Commercial potential • Technical advantages • Protectability • Inventor profile 100,000 disclosures (discoveries) Opportunity Assessment (Triage) 50% do not move forward 50,000 Patent Applications (10% lics / 2.5% discl.) License Income (0.5%) 25% 2,500 Start - ups 125 > $1M/year 25,000 Licenses 50% <$10k cum. Positive exit (liquidation)

  17. The Annual Survey tells: What we do. The Better World Report tells: How well we do it.

  18. AUTM’s Better World Project • Telling the story of the outcomes of technology transfer in human terms • An e-database of stories from Canada, the US, the UK. • Two publication (and e-versions) with stories highlighting social and economic impact • Of the 125 stories, 20% were products developed by university licensed start-up companies. • Anecdotal evidence to supplement our Licensing data.

  19. Why is AUTM doing this? To communicate the value of academic technology transfer

  20. TPMT: Diagnostic Test to Tailor Drug Dosage to Genetic Profile St. Jude Children's Research Hospital Sponsored Programs Database WesternKentucky Univ. KY Tactical Mobile Power Technology: 10-kilowatt Vehicular Power Source (VPS-10K) Mississippi State Univ. Restasis Univ. of Georgia TN Falconview Georgia Inst. of Technology MS Optigrate Inc. Method of Developing Holograms Univ. of Central Florida AL GA FoodSource Lures Auburn Univ. Chirp Sonar to Locate Underwater Buried Objects Florida Atlantic Univ. FL AU MEDSAuburn Univ. Partners for a Healthy Baby: Home Visiting Curriculum Florida State University Helping Emphysema Victims BreatheAgain Univ. of Florida Underwater In-Situ Mass Spectrometer Univ. of South Florida

  21. Diverse Markets Agriculture 28 Biotechnology 23 Chemical 9 Computer 8 Construction 5 Educational 18 Electronics 23 Environment 9 Food 7 Health Services 12 Information Services 6 Machinery 3 Medical 102 Miscellaneous 29 Pharmaceuticals 57 Software 18 TOTAL 357

  22. The Real Issues – Culture • Companies value secrecy. Universities value dissemination of information; • Companies value the bottom line. Universities value peer appreciation; • Companies define the direction of research. Faculty follow the research results. • Companies value attribution via patents. Faculty value attribution by publications

  23. More information: www.autm.net Jfraser@techtransfer.fsu.edu

  24. Macro Success Factors Innovation Climate (Start-Ups) - treatment of entrepreneurs - financial environment - risk tolerance - liquidity of investments - demographics of country/city Innovation Climate (Existing Companies) - NIH, globalization

More Related